<code id='437F8A11BD'></code><style id='437F8A11BD'></style>
    • <acronym id='437F8A11BD'></acronym>
      <center id='437F8A11BD'><center id='437F8A11BD'><tfoot id='437F8A11BD'></tfoot></center><abbr id='437F8A11BD'><dir id='437F8A11BD'><tfoot id='437F8A11BD'></tfoot><noframes id='437F8A11BD'>

    • <optgroup id='437F8A11BD'><strike id='437F8A11BD'><sup id='437F8A11BD'></sup></strike><code id='437F8A11BD'></code></optgroup>
        1. <b id='437F8A11BD'><label id='437F8A11BD'><select id='437F8A11BD'><dt id='437F8A11BD'><span id='437F8A11BD'></span></dt></select></label></b><u id='437F8A11BD'></u>
          <i id='437F8A11BD'><strike id='437F8A11BD'><tt id='437F8A11BD'><pre id='437F8A11BD'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:99

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Arc Institute generative AI designs new CRISPR systems
          Arc Institute generative AI designs new CRISPR systems

          PatrickHsu,co-founderoftheArcInstitute,speaksduringtheSTATBreakthroughSummitWestinSanFranciscoThursd

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

          MattRourke/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsle